Clinical trial
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With…
NCT00236015 · Cephalon, Industry · Completed
Key facts
| NCT number | NCT00236015 |
|---|---|
| Title | A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder |
| Official title | A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Gabitril at 4, 8, and 12 mg/Day in the Treatment of Adults With Generalized Anxiety Disorder. |
| Lead sponsor | Cephalon, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Gabitril |
| Enrollment | 880 |
| Start date | Nov 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Oct 12, 2005 |
| Last update posted | May 9, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: